首页 | 本学科首页   官方微博 | 高级检索  
检索        

2008-2009年乐山市麻疹强化免疫效益分析
引用本文:魏承斌,郭志鸿,林红,杨康林,秦利平,周潇,王佳.2008-2009年乐山市麻疹强化免疫效益分析[J].预防医学情报杂志,2010,26(12):944-946.
作者姓名:魏承斌  郭志鸿  林红  杨康林  秦利平  周潇  王佳
作者单位:乐山市疾病预防控制中心,四川乐山614000
基金项目:乐山市科技局重点研究计划支持项目
摘    要:目的通过研究麻疹强化免疫的投入和产出,分析强化免疫对控制麻疹的经济效益。方法通过测量麻疹强化免疫的成本、效果、效益,进行成本效果和成本效益分析。结果 2008-2009年乐山市麻疹强化免疫预测可减少发病755~1057例;可以产生2369190~3316866元的经济效益;成本效果分析,每投入3668.9元到2620.6元可减少1例麻疹患者;成本效益比=1∶0.86~1.20,中间值为1∶1.03。结论麻疹强化免疫经济上投入产出相当。

关 键 词:麻疹  强化免疫  成本效果分析  成本效益分析

Cost-Benefit Analysis of Measles Supplementary Immunization Activity in Leshan
Institution:WEI Cheng-bin, GUO Zhi-hong, LIN Hong, et al.Leshan Municipal Center for Disease Control and Prevention,Leshan 614000, Sichuan Province,China.
Abstract:Objective To evaluate the cost-benefit of measles supplemented immunization activity (SIA) in Leshan.Methods The cost-effect and cost-benefit of the SIA in Leshan were analyzed. Results It is estimated that the SIA during 2008-2009 might have reduced 755-1 507 measles cases and produced the benefit of 2 369 190 to 3 316 866 yuan. One measles case could be reduced at the cost of 3 668.9 yuan to 2620.6 yuan. The cost-benefit ratio of the SIA was 1∶0.86 to 1∶1.20 (medians:1:1.03).Conclusion SIA in Leshan during 2008-2009 was with cost-benefit.
Keywords:Measles  Supplementary immunization  Activity  Cost effect analysis  Cost benefit analysis
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号